Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Change in Accured Expenses (2020 - 2026)

Journey Medical filings provide 6 years of Change in Accured Expenses readings, the most recent being $6.4 million for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 349.82% to $6.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $10.1 million, a 446.97% increase, with the full-year FY2025 number at $10.1 million, up 446.97% from a year prior.
  • Change in Accured Expenses hit $6.4 million in Q4 2025 for Journey Medical, up from $3.8 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $14.3 million in Q2 2021 to a low of -$10.5 million in Q3 2021.
  • Median Change in Accured Expenses over the past 5 years was $35500.0 (2022), compared with a mean of $424050.0.
  • The widest YoY moves for Change in Accured Expenses: up 35681.82% in 2023, down 8643.75% in 2023.
  • Journey Medical's Change in Accured Expenses stood at -$2.1 million in 2021, then surged by 101.65% to $35000.0 in 2022, then tumbled by 37.14% to $22000.0 in 2023, then surged by 6340.91% to $1.4 million in 2024, then soared by 349.82% to $6.4 million in 2025.
  • The last three reported values for Change in Accured Expenses were $6.4 million (Q4 2025), $3.8 million (Q3 2025), and -$5.6 million (Q2 2025) per Business Quant data.